Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial).
Midas B MulderErwin BirnieCaroline van Dijck-van BoetzelaerGert-Jan van de GeijnEgbert BoevéElsbeth M WestermanPaul HambergPublished in: Acta oncologica (Stockholm, Sweden) (2020)
Keyphrases
- prostate cancer
- locally advanced
- randomized controlled trial
- study protocol
- squamous cell carcinoma
- rectal cancer
- radical prostatectomy
- neoadjuvant chemotherapy
- small cell lung cancer
- replacement therapy
- clinical trial
- radiation therapy
- phase ii study
- phase ii
- bone marrow
- mesenchymal stem cells
- placebo controlled
- smoking cessation